Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking
-
Letter to House Leadership Urging Passage of Telehealth Expansion Act of 2023
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Request to FDA to Extend Comment Period for Proposed Rule on Regulation of LDTs
-
Letter to Senate Leadership Urging Passage of Telehealth Expansion Act of 2023
-
ACMG & ABMGG Joint Response to Supreme Court Ruling on Affirmative Action
-
Sign-on Letter Supporting the Telehealth Expansion Act
-
ACMG Response to NYS on Proposed Changes to Onsite Work Requirements for Lab Directors
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities